mefenamic acid and pf 04971729

mefenamic acid has been researched along with pf 04971729 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Han, DG; Yoon, IS; Yun, H1
Callegari, E; Goosen, TC; Lin, J; Sahasrabudhe, V; Tse, S1

Trials

1 trial(s) available for mefenamic acid and pf 04971729

ArticleYear
Physiologically-Based Pharmacokinetic Modeling of the Drug-Drug Interaction of the UGT Substrate Ertugliflozin Following Co-Administration with the UGT Inhibitor Mefenamic Acid.
    CPT: pharmacometrics & systems pharmacology, 2021, Volume: 10, Issue:2

    Topics: Adult; Area Under Curve; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase Inhibitors; Drug Interactions; Female; Glucuronosyltransferase; Healthy Volunteers; Humans; Male; Mefenamic Acid; Middle Aged; Models, Biological; Sodium-Glucose Transporter 2 Inhibitors; UDP-Glucuronosyltransferase 1A9; Uridine

2021

Other Studies

1 other study(ies) available for mefenamic acid and pf 04971729

ArticleYear
A novel high-performance liquid chromatographic method combined with fluorescence detection for determination of ertugliflozin in rat plasma: Assessment of pharmacokinetic drug interaction potential of ertugliflozin with mefenamic acid and ketoconazole.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019, Aug-01, Volume: 1122-1123

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Drug Interactions; Ketoconazole; Limit of Detection; Linear Models; Male; Mefenamic Acid; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Spectrometry, Fluorescence

2019